Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
DHE)
.
Show all posts
Showing posts with label
DHE)
.
Show all posts
Friday, May 27, 2011
MAP Pharmaceuticals submits LEVADEX NDA to FDA for treatment of migraine in adults
›
Levadex is designed to be differentiated from existing migraine treatments. It is a novel formulation of dihydroergotamine (see above...
›
Home
View web version
